Jade Biosciences, Inc. · NASDAQ:JBIO
Frazier Life Sciences Public Fund, L.P. reported a 4.20% stake in Jade Biosciences, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Frazier Life Sciences Public Fund, L.P. reported a 4.20% stake in Jade Biosciences, Inc., 1,340,703 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 4.20%
- Shares
- 1,340,703
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 17 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 4.20% | 1,340,703 |
| FHMLSP, L.P. | 4.20% | 1,340,703 |
| FHMLSP, L.L.C. | 4.20% | 1,340,703 |
| Frazier Life Sciences Public Overage Fund, L.P. | 1.20% | 395,508 |
| FHMLSP Overage, L.P. | 1.20% | 395,508 |
| FHMLSP Overage, L.L.C. | 1.20% | 395,508 |
| Frazier Life Sciences X, L.P. | 0% | 11,897 |
| FHMLS X, L.P. | 0% | 11,897 |
| FHMLS X, L.L.C. | 0% | 11,897 |
| Frazier Life Sciences XI, L.P. | 0.10% | 24,008 |
| FHMLS XI, L.P. | 0.10% | 24,008 |
| FHMLS XI, L.L.C. | 0.10% | 24,008 |
| James N. Topper | 0% | 11,897 |
| Patrick J. Heron | 0% | 11,897 |
| Albert Cha | 0% | 0 |
| James Brush | 0% | 0 |
| Daniel Estes | 0% | 0 |
Source
Related
- Jade Biosciences, Inc.
- Frazier Life Sciences Public Fund, L.P.
- Jade Biosciences, Inc. shareholders
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Nov 14, 2025
- Schedule 13G · Frazier Life Sciences Public Fund, L.P. · May 5, 2025
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · Aug 14, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Jul 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Jul 8, 2026
- Schedule 13D/A · Fairmount Funds Management LLC · Jun 9, 2026